首页> 美国卫生研究院文献>PLoS Clinical Trials >Pharmacological Inhibition of Caspase and Calpain Proteases: A Novel Strategy to Enhance the Homing Responses of Cord Blood HSPCs during Expansion
【2h】

Pharmacological Inhibition of Caspase and Calpain Proteases: A Novel Strategy to Enhance the Homing Responses of Cord Blood HSPCs during Expansion

机译:Caspase和钙蛋白酶蛋白酶的药理学抑制作用:一种新的策略,以扩大脐带血HSPCs在扩张过程中的归巢反应。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundExpansion of hematopoietic stem/progenitor cells (HSPCs) is a well-known strategy employed to facilitate the transplantation outcome. We have previously shown that the prevention of apoptosis by the inhibition of cysteine proteases, caspase and calpain played an important role in the expansion and engraftment of cord blood (CB) derived HSPCs. We hypothesize that these protease inhibitors might have maneuvered the adhesive and migratory properties of the cells rendering them to be retained in the bone marrow for sustained engraftment. The current study was aimed to investigate the mechanism of the homing responses of CB cells during expansion.
机译:背景技术扩增造血干/祖细胞(HSPC)是用于促进移植结果的众所周知的策略。先前我们已经表明,通过抑制半胱氨酸蛋白酶,胱天蛋白酶和钙蛋白酶来预防凋亡在脐血(CB)衍生的HSPC的扩增和移植中起着重要作用。我们假设这些蛋白酶抑制剂可能已经操纵了细胞的粘附和迁移特性,使它们被保留在骨髓中以持续植入。当前的研究旨在研究CB细胞在扩增过程中的归巢反应机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号